We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTEC:NASDAQTTEC Holdings, Inc. Analysis

Data as of 2026-06-24 - not real-time

$2.10

Latest Price

8/10Risk

Risk Level: High

Executive Summary

TTEC is trading at $2.10, well below its 20‑day ($2.37), 50‑day ($2.66) and 200‑day ($3.03) simple moving averages, signaling a bearish price environment. RSI sits at 35, hinting at modest oversold pressure, while the MACD histogram remains negative, confirming downside momentum. Volume is rising, but the stock is highly volatile (30‑day volatility ~68%) and exhibits a beta near 2, indicating strong sensitivity to market swings. On the fundamentals side, the company reports a negative profit margin (‑9.6%), a troubling debt‑to‑equity ratio above 950%, and no dividend, yet its discounted cash‑flow model suggests a fair value around $6.55 – implying a potential upside of roughly 90% if the business can reverse its earnings trend.
Given the mix of technical weakness, heavy leverage, and a sizable valuation gap, any upside hinges on a successful turnaround in its CX services and AI offerings. Until earnings improve and balance sheet risk eases, the stock remains a high‑risk play despite the attractive price relative to its DCF estimate.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish trend
  • Negative MACD and RSI below 40 suggest continued downside
  • High volatility and beta amplify short‑term risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Substantial DCF upside if earnings recover
  • Heavy debt load limits flexibility
  • Increasing volume may precede a reversal but fundamentals remain weak

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value implies significant upside potential
  • Growth opportunities in AI‑driven CX services
  • Market sentiment (Extreme Greed) could support a price rally if turnaround succeeds

Key Metrics & Analysis

Financial Health

Revenue Growth-7.10%
Profit Margin-9.60%
P/E Ratio1.7
ROE-100.97%
ROA3.65%
Debt/Equity956.55
P/B Ratio1.1
Op. Cash Flow$127.0M
Free Cash Flow$91.7M
Industry P/E36.7

Technical Analysis

TrendBearish
RSI35.0
Support$1.99
Resistance$2.82
MA 20$2.37
MA 50$2.66
MA 200$3.03
MACDBearish
VolumeIncreasing
Fear & Greed Index87.13

Valuation

Fair Value$6.55
Target Price$4.00
Upside/Downside90.48%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.97
Volatility68.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.